Dimension Capital II L.P. insider trades
Open-market stock purchases and sales by Dimension Capital II L.P., Director at Odyssey Therapeutics, Inc, from SEC Form 4 filings since May 8, 2026.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +6%.
Companies traded
- ODTX Odyssey Therapeutics, Inc: 1 buy, last May 8, 2026
Get free alerts when Dimension Capital II L.P. files a new trade →